Naomi Gronich - Epidemiology

Author Information

Naomi Gronich is affiliated with the Community Medicine and Epidemiology department at Lady Davis Carmel Medical Center, located in Haifa, Israel. Her work primarily focuses on population-based studies and real-world research in the fields of pharmacology, epidemiology, and public health.

Research Contributions

Naomi Gronich has made significant contributions to the field of epidemiology and pharmacology through her research on various health conditions and their treatments. Her recent work includes studies on the association between medications and conditions such as Stevens-Johnson Syndrome, toxic epidermal necrolysis, and the effectiveness of proton pump inhibitors influenced by CYP2C19 polymorphism. She has also investigated the risks associated with vaccination, particularly the BNT162b2 mRNA COVID-19 vaccine, and its link to Bell's palsy. Other notable research includes studies on the safety and effectiveness of anticoagulants, the risks of stroke and bleeding in atrial fibrillation patients, and the long-term outcomes of EGFR mutated NSCLC cases. Her work often utilizes real-world data, providing valuable insights into the practical implications of medical treatments.

Aliases

Naomi Gronich is also known by the aliases N Gronich, N. Gronich, and Naomi Gronich.

Publication and Citation Metrics

Metric	Value
Total Citations	1303
h-index	20
Number of Papers	53

Publications:

Culprit Medications and Risk Factors Associated with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case–Control Study

DOI: 10.1007/s40257-021-00661-0

Year: 2022

Association of CYP2C19 Polymorphism With Proton Pump Inhibitors Effectiveness and With Fractures in Real‐Life: Retrospective Cohort Study

DOI: 10.1002/cpt.2552

Year: 2022

Association between vaccination with the BNT162b2 mRNA COVID-19 vaccine and Bell's palsy: a population-based study

DOI: 10.1016/j.lanepe.2021.100236

Year: 2021

Novel bleeding prediction model in atrial fibrillation patients on new oral anticoagulants

DOI: 10.1136/heartjnl-2021-319702

Year: 2021

Ischemic stroke and myocardial ischemia in clopidogrel users and the association with CYP2C19 loss-of-function homozygocity: a real-world study.

DOI: 10.1038/s41397-021-00218-8

Year: 2021

Association Between Use of Pharmacokinetic‐Interacting Drugs and Effectiveness and Safety of Direct Acting Oral Anticoagulants: Nested Case‐Control Study

DOI: 10.1002/cpt.2369

Year: 2021

Stroke and Bleeding Risks in Patients with Atrial Fibrillation Treated with Reduced Apixaban Dose: A Real‐Life Study

DOI: 10.1002/cpt.1952

Year: 2020

Long term follow-up of EGFR mutated NSCLC cases

DOI: 10.1016/j.tranon.2020.100934

Year: 2020

Use of metformin and risk of breast and colorectal cancer.

DOI: 10.1016/j.diabres.2020.108232

Year: 2020

Reply to: From beta‐blockers to Parkinson's disease in respect of essential tremor

DOI: 10.1002/mds.27589

Year: 2019

What is the Role of Remote Sensing in Epidemiology?

What Are the Challenges in Air Sampling?

Why Are Policy Reforms in Epidemiology Essential?

What Role Does Genetic Information Play?

What are Common Challenges in Epidemiology?

What Does "In Transit" Mean in Epidemiology?

Why are Data Analysis Services Important?

How Do Toilets Help in Disease Prevention?

What is a Minority Community?

How Does Taha Hinengaro Interact with Other Taha in Te Whare Tapa Whā?

Partnered Content Networks

Relevant Topics